How Medacta Continues to Drive Above-Market Growth
We spoke with Medacta CEO Francesco Siccardi about what is driving the company’s strong sales, knee replacement market shifts and orthopedic market opportunities. May 23, 2024
We've found 300 results
Top Orthopedic Executives Look Back on 2023
We gathered quotes from top orthopedic executives as they reflected on enabling technology, procedure demand and M&A integration progress. Mar 07, 2024
Stryker Talks Tidal Wave Opportunity for Total Ankle Replacement
We talked to Michael Rankin about Stryker's view of enabling technology in foot and ankle as well as future demand in the ASC. Feb 29, 2024
Joint Replacement Makes Up For Lost Time in 2023
Backlogged procedures drove much of the robust demand for joint replacement in 2023 but more durable tailwinds could also be taking hold. Feb 16, 2024
Orthopedic Funding Slows, Focuses on Digital
While economic pressure slowed orthopedic funding in recent years, there is ample capital for enabling technology companies. Feb 06, 2024
Equity Markets: Is It Time to Worry?
Orthopedic investors are prioritizing later-stage companies with a clear path to commercialization and profitability. Dec 11, 2023
Xtant Medical Set for Growth After Realignment and Acquisitions
Xtant Medical's CEO has turned around the company by reengaging the team, optimizing business processes and acquiring products. Nov 16, 2023
Enovis Foot and Ankle Sets Sights on Top Three Position
We chatted with Gary Justak, President of Enovis’ Foot and Ankle business, about R&D focus, managing integrations and long-term goals. Oct 02, 2023
Are Your Customer Needs Effectively Driving Your Marketing Strategy?
Strategic development of a go-to-market strategy is paramount for orthopedic companies that seek to win in the evolving healthcare landscape. Sep 21, 2023
Zimmer Biomet Appoints Ivan Tornos as President and CEO
Bryan Hanson, who has served as President and CEO since late 2017, is departing to take on another CEO role. Aug 22, 2023
